CoD: Warzone 2 Loadout Drops Return To Buy Stations

Loadout drops can be purchased once again, and here's how much they cost.

Comments

Following the launch of the Season 1 Reloaded update, Raven Software has slowly been making several small tweaks to Call of Duty: Warzone 2, including bringing back the battle royale's option to purchase a Loadout Drop Marker from Buy Stations.

The developer tweeted on December 20 that purchasable loadout drops returned to the battle royale with a small update. These can be found in Buy Stations across Al Mazrah, bringing back Warzone's traditional custom loadout with weapons, perk packages, and equipment.

Please use a html5 video capable browser to watch videos.
This video has an invalid file format.
00:00:00
Sorry, but you can't access this content!
Please enter your date of birth to view this video

By clicking 'enter', you agree to GameSpot's
Terms of Use and Privacy Policy

Now Playing: 19 Things I Wish I Knew About DMZ In Call Of Duty: Modern Warfare 2

Players can now buy their loadout drop at the following prices:

  • Solos - $8,000
  • Duos - $16,000
  • Trios - $24,000
  • Quads - $32,000

Raven Software did add an additional tweet to say that the continued availability of these loadouts will depend on feedback received and the overall impact on the experience in Warzone 2, so purchasable loadout drops are subject to change.

The return of loadout drops comes one day after a Warzone 2 update reduced the Buy Station's cost of primary loadout weapons from $5,000 to $2,500 per weapon.

Season 1 Reloaded added two operators, the new Chimera assault rifle, and more. Make sure to check out all the Season 1 Reloaded changes revealed in the patch notes for Modern Warfare 2 and Warzone 2, which includes an overhaul of social tab, bug fixes, and weapon tuning.

The products discussed here were independently chosen by our editors. GameSpot may get a share of the revenue if you buy anything featured on our site.

Got a news tip or want to contact us directly? Email news@gamespot.com

Join the conversation
There are no comments about this story